切换至 "中华医学电子期刊资源库"

中华肥胖与代谢病电子杂志 ›› 2019, Vol. 05 ›› Issue (04) : 196 -200. doi: 10.3877/cma.j.issn.2095-9605.2019.04.004

所属专题: 文献

论著

不同剂量丙泊酚麻醉对病态肥胖患者肝肾功能的影响
潘桂烽1, 彭雪梅1,()   
  1. 1. 510000 广州,暨南大学附属第一医院麻醉科
  • 收稿日期:2019-10-24 出版日期:2019-11-30
  • 通信作者: 彭雪梅

Effects of different doses of propofol on hepatic and renal function in morbid obese patients undertook bariatric surgery

Guifeng Pan1, Xuemei Peng1,()   

  1. 1. Department of Anesthesiology, the First Affiliated Hospital of Jinan University, GuangZhou 510000, China
  • Received:2019-10-24 Published:2019-11-30
  • Corresponding author: Xuemei Peng
  • About author:
    Corresponding author: Peng Xuemei, Email:
引用本文:

潘桂烽, 彭雪梅. 不同剂量丙泊酚麻醉对病态肥胖患者肝肾功能的影响[J/OL]. 中华肥胖与代谢病电子杂志, 2019, 05(04): 196-200.

Guifeng Pan, Xuemei Peng. Effects of different doses of propofol on hepatic and renal function in morbid obese patients undertook bariatric surgery[J/OL]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2019, 05(04): 196-200.

目的

探讨分别按去脂体质量(LBW)、总体质量(TBW)2种剂量使用丙泊酚麻醉对病态肥胖患者行减重术术后肝肾功能的影响。

方法

选择23例ASAI~II级拟行减重手术的患者,随机分为TBW组(I组),LBW组(II组),另选一组正常体重进行腹腔镜手术患者(III组)为对照,使用分别采用不同剂量丙泊酚进行麻醉,记录术前(T1)、术后24 h(T2)、48 h(T3)、72 h(T4)的血清天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)、白蛋白(ALB)、尿素氮(BUN)和β2微球蛋白(β2-MG)等肝肾功能指标。

结果

3组患者组内不同时间点上AST、ALT等肝功能指标的差异无统计学意义(P>0.05),与T1相比,3组患者内的ALB、BUN在T3、T4明显降低(P<0.05);与T1相比,3组内的β2-微球蛋白在T2、T3时间点明显下降(P<0.05)。

结论

对于病态肥胖患者,两种剂量丙泊酚麻醉对病态肥胖患者的肝肾功能无明显影响,为减少丙泊酚输注综合征等并发症的发生,推荐LBW作为丙泊酚的给药剂量。

Objective

To compare the effects of propofol anesthesia on liver and kidney function after weight-loss surgery within two different dose.

Methods

23 ASA class I or II morbid obese patients (BMI≥35 kg/m2) undergoing bariatric surgery will be randomly divided into total body weight grope (group I involved 11 cases) and lean body weight group (group II involved 12 cases) . Another 6 ASA I- II normal weight patients (BMI of 18.5-24 kg/m2) undergoing laparoscopic surgery were enrolled for contrast (group III) . They received defferent dose propofol for anesthesia. Renal and hepatic functions were detected before and on the 6h (T1), 24h (T2), and 72h (T3) after withdrawal propofol, such as serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), albumin (ALB), urea nitrogen (BUN) and β2-microglobulin (β2-MG) and so on.

Results

There were no significant differences in liver function indexes such as AST and ALT at different time point in three groups. Compared with T1, ALB and BUN in the three groups of patients was significantly decrease in T3 and T4 (P<0.05); Compared with T1, B2-microglobulin in the three groups decreased significantly in T2-T3 (P<0.05).

Conclusions

For morbidly obese patients, two different doses of propofol anesthesia have no significant effect on liver and kidney function in morbidly obese patients. To reduce the complications of propofol infusion syndrome, LBW is recommended as the dose of propofol.

表1 三组患者一般情况的比较
表2 三组患者肝肾功能变化
表3 三组患者β2-MG变化
[1]
Kam PC, Cardone D. Propofol infusion syndrome[J]. Anaesthesia, 2007, 62(7): 690-701.
[2]
潘阳阳,乔南南,赵芳玉, 等. 病态肥胖患者丙泊酚的药代动力学及麻醉应用研究进展[J]. 国际麻醉学与复苏杂志, 2019, 40(3): 286-288.
[3]
SantAnna MJ, Carvalhal RF, Oliveira FD, et al. Respiratory mechanics of patients with morbid obesity[J]. Jornal Brasileiro de Pneumologia, 2019, 45(5): e20180311.
[4]
Robinson PD. Obesity and its impact on the respiratory system[J]. Paediatric Respiratory Reviews, 2014, 15(3): 219-226.
[5]
De Jone A, Verzilli D, Geniez M, et al. Why is the morbidly obese patient at high risk of anesthetic complications? [J]. La Presse Médicale, 2018, 47(5): 453-463.
[6]
Murphy, GS, Szokol JW, Marymont JH, et al., Residual Neuromuscular Blockade and Critical Respiratory Events in the Postanesthesia Care Unit[J]. Anesthesia & Analgesia, 2008, 107(1): 130-137.
[7]
Bahattin T, Yonca OP, Asude A, et al. Retrospective Evaluation of Patients who Underwent Laparoscopic[J]. Bariatric Surgery, 2018, 46(4): 297-304.
[8]
Janmahasatian S, Duffull DS, Ash S, et al. Quantification of Lean Bodyweight[J]. Clinical Pharmacokinetics, 2005, 44(10): 1051-1065.
[9]
Wang YS, Qiu RG, Kong GY, et al. Effects of propofol combined with remifentanil anesthesia on the NO, endothelin and inflammatory cytokines in the plasma of patients with liver cirrhosis during the perioperative period[J]. Experimental and Therapeutic Medicine, 2019, 17(5): 3694-3700
[10]
Lee HJ, Bae JY, Kwon YS, et al. General Anesthetic Agents and Renal Function after Nephrectomy[J]. Joural of Clinical Medicine, 2019, 8(10): 1530
[11]
廖武豪,邹启荣,蒋德英, 等. 不同麻醉诱导剂量丙泊酚对病态肥胖患者心脏泵功能的影响[J]. 实用医学杂志, 2017, 33(24): 4145-4148.
[12]
Braz MG, Braz LG, Freire CM, et al. Isoflurane and Propofol Contribute to Increasing the Antioxidant Status of Patients During Minor Elective Surgery[J]. Medicine (Baltimore), 2015, 94(31): 1266.
[13]
Yagmurdur H, Binnetoglu K, Astarci HM, et al. Propofol attenuates cytokine-mediated upregulation of expression of inducible nitric oxide synthase and apoptosis during regeneration post-partial hepatectomy[J]. Acta Cirurgica Brasileira, 2017, 32(5): 396-406.
[14]
罗辉遇,谢长江,刘卫江, 等. 大手术重症患者血清白蛋白水平的变化及临床意义[J]. 实用医学杂志, 2006, 22(12): 1400-1401.
[15]
Lnker LA, Tighiouart H, Coresh J, et al. GFR estimation using β-trace protein and β2-microglobulin in CKD[J]. Am J Kidney Dis, 2016, 67(1): 40-48.
[16]
Tian HT, Duan XH, Yang YF, et al. Effects of propofol or sevoflurane anesthesia on the perioperative inflammatory response, pulmonary function and cognitive function in patients receiving lung cancer resection[J]. European Review for Medical & Pharmacological Sciences, 2017, 21(23): 5515.
[17]
Han C, Ding W, Jiang W, et al. A comparison of the effects of midazolam, propofol and dexmedetomidine on the antioxidant system: A randomized trial[J]. Experimental And Therapeutic Medicine, 2015, 9(6): 2293-2298.
[18]
Tao T, Li CL, Yang WC, et al. Protective effects of propofol against whole cerebral ischemia/reperfusion injury in rats through the inhibition of the apoptosis-inducing factor pathway[J]. Brain Research, 2016, 1644: 9-14.
[19]
Roh GU, Song Y, Park J, et al. Effects of propofol on the inflammatory response during robot-assisted laparoscopic radical prostatectomy: a prospective randomized controlled study[J]. Scientific Reports, 2019, 9: 5242.
[20]
Gallego L, Soro M, Alvari OA, et al. Renal and hepatic integrity in long-term sevoflurane sedation using the anesthetic conserving device: A comparison with intravenous propofol sedation in an animal model[J]. Revista Española de Anestesiología y Reanimación (English Edition), 2015, 62(4): 191-203.
[1] 向韵, 卢游, 杨凡. 全氟及多氟烷基化合物暴露与儿童肥胖症相关性研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 569-574.
[2] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[3] 孟令凯, 李大勇, 王宁, 王桂明, 张炳南, 李若彤, 潘立峰. 袖状胃切除术对肥胖伴2型糖尿病大鼠的作用及机制研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 638-642.
[4] 李猛, 姜腊, 董磊, 吴情, 贾犇黎. 腹腔镜胃袖状切除术治疗肥胖合并2型糖尿病及脂肪胰的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 554-557.
[5] 杨波, 胡旭, 何金艳, 谢铭. 腹腔镜袖状胃切除术管胃固定研究现状[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 452-455.
[6] 吉顺富, 汤晓燕, 徐进. 腹腔镜近端胃癌根治术中拓展胃后间隙在肥胖患者中的应用研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 393-396.
[7] 玉素江·图荪托合提, 韩琦, 麦麦提艾力·麦麦提明, 黄旭东, 王浩, 克力木·阿不都热依木, 艾克拜尔·艾力. 腹腔镜袖状胃切除或联合食管裂孔疝修补术对肥胖症合并胃食管反流病的中期疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 501-506.
[8] 刘见, 杨晓波, 何均健, 等. 应用电钩三孔法腹腔镜袖状胃切除术[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(06): 363-364.
[9] 谢浩文, 丁建英, 刘小霞, 冯毅, 姚婧. 椎旁神经阻滞对微创胃切除肥胖患者术中血流、术后应激及康复质量的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 569-573.
[10] 王星, 陈园, 热孜万古丽·乌斯曼, 郭艳英. T2DM、Obesity、NASH、PCOS共同致病因素相关的分子机制[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 481-490.
[11] 中国医师协会外科医师分会肥胖代谢病综合管理与护理专家工作组, 中国医师协会外科医师分会肥胖和代谢病外科专家工作组, 中国肥胖代谢外科研究协作组. 肥胖代谢外科医学科普中国专家共识(2024 版)[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 227-234.
[12] 向林, 江云颂, 程吕佳, 关炳生, 杨景哥. 生长素释放肽在肥胖治疗中的潜在应用价值研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 235-241.
[13] 王鹏鹏, 周涵苓, 孟化, 刘宝胤. 减重手术后皮肤松弛的塑形手术现状与展望[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 248-254.
[14] 张鑫, 刘志芬, 郭云童. 肥胖与抑郁症相关性的研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 255-260.
[15] 王超珺, 刘昭晖. 肌肉减少型肥胖的诊疗进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 269-275.
阅读次数
全文


摘要